Cell Genesys Reports Fourth Quarter and Year-End 20...(ect ourintellectual property litigation ...),Health

Date:2/28/2008

ect our intellectual property, litigation or other claims, the need for and reliance on collaborative business relationships and strategic partnerships with third parties, and the need for additional financings. For information about these and other risks which may affect Cell Genesys, please see the company's reports on Form 10-Q, 10-K, and 8-K and other reports filed from time to time with the Securities and Exchange Commission. The company assumes no obligation to update the forward-looking information in this press release.

Contact:

Susan Ferris

Investor Relations

650-266-3200

-- FINANCIAL CHARTS TO FOLLOW --

SELECTED CONSOLIDATED FINANCIAL INFORMATION

CONSOLIDATED STATEMENTS OF OPERATIONS DATA

(unaudited, in thousands, except per share data)

Three months ended Twelve months ended

December 31, December 31,

2007 2006 2007 2006

Revenue $102 $90 $1,380 $1,364

Operating expenses:

Research and development 28,457 24,633 106,131 96,346

General and administrative 5,260 4,435 20,401 18,123

Restructuring charges - (25) - (82)

Total operating expenses 33,717 29,043 126,532 114,387

Loss from operations (33,615) (28,953) (125,152) (113,023)

Other income (expense):

Gain on sale of Abgenix,

Inc. common stock - - - 62,677

Gain (loss) on sale of

property and equipment (3) - 1,306 (2)

Interest and other income 2,919 2,088 9,021 7,497

Interest expense (2,570) (2,607) (1
'/>"/>

SOURCE Cell Genesys, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6
Related medicine news :

1. Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results
2. MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results
3. Pharmos Corporation Reports 2007 Fourth Quarter and Year-end Results
4. Public Health Officials Warn About the Unrecognized Health Hazards of Smoking from a Hookah, Reports the Harvard Mental Health Letter
5. inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007
6. Hospira Reports Fourth-Quarter and Full-Year 2007 Results
7. KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis
8. Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter
9. Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter
10. J.D. Power and Associates Reports: Riverview Medical Center Recognized for Providing an Emergency Department Experience
11. LifeCell Reports Fourth Quarter and Full Year 2007 Financial Results